OpenAI Launches GPT-Rosalind to Speed Drug Discovery

Scientists just got a powerful new research partner that could cut years off drug development timelines.

OpenAI's GPT-Rosalind, named after DNA pioneer Rosalind Franklin, is the first AI model built specifically to accelerate biology and medicine breakthroughs.